148 related articles for article (PubMed ID: 36081505)
1. Analysis of immune status in gastric adenocarcinoma with different infiltrating patterns and origin sites.
Zhang N; Wang D; Hu X; Zhang G; Li Z; Zhao Y; Liu Z; Wang Y
Front Immunol; 2022; 13():978715. PubMed ID: 36081505
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
[TBL] [Abstract][Full Text] [Related]
3. Tumor infiltration pattern into the surrounding tissue has prognostic significance in advanced gastric cancer.
Saito H; Miyatani K; Takaya S; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ikeguchi M
Virchows Arch; 2015 Nov; 467(5):519-23. PubMed ID: 26277483
[TBL] [Abstract][Full Text] [Related]
4. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumour infiltration growth pattern in patients with advanced gastric cancer.
Zhao B; Zhang J; Mei D; Huang X; Zou S; Luo R; Xu H; Huang B
J Clin Pathol; 2019 Feb; 72(2):165-171. PubMed ID: 30467239
[TBL] [Abstract][Full Text] [Related]
6. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.
Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH
Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841
[TBL] [Abstract][Full Text] [Related]
8. Differences in immune contextures among different molecular subtypes of gastric cancer and their prognostic impact.
Kim JY; Kim WG; Kwon CH; Park DY
Gastric Cancer; 2019 Nov; 22(6):1164-1175. PubMed ID: 31152268
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with Mechanistic Target of Rapamycin Signaling.
Nakazawa N; Sohda M; Katayama A; Ide M; Shimoda Y; Tateno K; Watanabe T; Sano A; Sakai M; Yokobori T; Ogawa H; Oyama T; Shirabe K; Saeki H
Oncology; 2023; 101(8):520-526. PubMed ID: 37315539
[TBL] [Abstract][Full Text] [Related]
10. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.
Fukuda K; Tsujitani S; Maeta Y; Yamaguchi K; Ikeguchi M; Kaibara N
Gastric Cancer; 2002; 5(4):220-7. PubMed ID: 12491080
[TBL] [Abstract][Full Text] [Related]
11. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
Li K; Zhu Z; Luo J; Fang J; Zhou H; Hu M; Maskey N; Yang G
Int J Clin Exp Pathol; 2015; 8(11):14725-32. PubMed ID: 26823797
[TBL] [Abstract][Full Text] [Related]
12. The special immune microenvironment of tumor budding and its impact on prognosis in gastric adenocarcinoma.
Zhang N; Wang D; Duan Y; Ayarick VA; Cao M; Wang Y; Zhang G; Wang Y
Pathol Res Pract; 2020 Jun; 216(6):152926. PubMed ID: 32327282
[TBL] [Abstract][Full Text] [Related]
13. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
14. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
[TBL] [Abstract][Full Text] [Related]
15. Association of tumor deposits with tumor-infiltrating lymphocytes and prognosis in gastric cancer.
Li X; Yang J
World J Surg Oncol; 2022 Feb; 20(1):58. PubMed ID: 35220959
[TBL] [Abstract][Full Text] [Related]
16. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
[TBL] [Abstract][Full Text] [Related]
17. Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers.
Kim JY; Kim CH; Lee Y; Lee JH; Chae YS
Pathology; 2017 Oct; 49(6):589-595. PubMed ID: 28843920
[TBL] [Abstract][Full Text] [Related]
18. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
19. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
